PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype

被引:22
作者
Danecek, Petr [1 ,2 ]
Lu, Wenzhe [1 ,2 ]
Schein, Catherine H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
vaccine design; arthropod-borne virus; dengue hemorrhagic disease; West Nile encephalitis; functional motifs; WEST-NILE-VIRUS; DOMAIN-III PROTEIN; BORNE ENCEPHALITIS-VIRUS; DENGUE HEMORRHAGIC-FEVER; TYPE-2 ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; CRYSTAL-STRUCTURE; TICK-BORNE; IMMUNE-RESPONSES; MOSQUITO-BORNE;
D O I
10.1016/j.jmb.2009.11.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Computational methods are needed to design multivalent vaccines against flaviviruses (FVs) such as the West Nile virus or the dengue virus (DENV). We aimed to use physicochemical property (PCP) consensus sequences of FV strains to delineate conserved motifs, areas of maximum variability, and specific loci that correlate with arthropod vector, serotype, and disease severity. PCP consensus sequences for 27 species were prepared from 928 annotated sequences catalogued in Flavitrack. Alignments of these correlated well with the known structures of the NS3 protease domain and envelope (E) proteins. The PCPMer suite was used to identify motifs Common to all FVs. Areas of PCP variability that correlated with phenotype were plotted on the structures. Despite considerable diversity at the amino acid level, PCPs for both proteins were well conserved throughout the FVs. A series of insertions in E separated tick- from mosquito-borne viruses and all arthropod-borne viruses from isolates with no known vector or directly from insects. Comparison of a PCP consensus sequence of E derived from 600 DENV strains (DENV600) with individual ones for DENV1-DENV4 showed that most major serotype-specific variation occurs near these insertions. The DENV600 differed from one prepared from eight hemorrhagic or fatal strains from four DENV serotypes at only three positions, two of which overlap known escape mutant sites. Comparing consensus sequences showed that substantial changes occur in only a few areas of the E protein. PCP consensus sequences can contribute to the design of multivalent vaccines. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:550 / 563
页数:14
相关论文
共 74 条
[1]   Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice [J].
Babu, J. Pradeep ;
Pattnaik, Priyabrata ;
Gupta, Nimesh ;
Shrivastava, Ambuj ;
Khan, Mohsin ;
Rao, P. V. Lakshmana .
VACCINE, 2008, 26 (36) :4655-4663
[2]   Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes [J].
Barker, Winona C. ;
Mazumder, Raja ;
Vasudevan, Sona ;
Sagripanti, Jose-Luis ;
Wu, Cathy H. .
VIRUS GENES, 2009, 39 (01) :1-9
[3]   Flavivirus DNA vaccine with a kick [J].
Barrett, Alan D. T. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :525-526
[4]   Current use and development of vaccines for Japanese encephalitis [J].
Beasley, David W. C. ;
Lewthwaite, Penny ;
Solomon, Tom .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) :95-106
[5]   The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry [J].
Chin, J. F. L. ;
Chu, J. J. H. ;
Ng, M. L. .
MICROBES AND INFECTION, 2007, 9 (01) :1-6
[6]   Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection [J].
Chu, Jang-Hann J. ;
Chiang, Cern-Cher S. ;
Ng, Mah-Lee .
JOURNAL OF IMMUNOLOGY, 2007, 178 (05) :2699-2705
[7]   Interaction of West Nile virus with αvβ3 integrin mediates virus entry into cells [J].
Chu, JJH ;
Ng, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54533-54541
[8]  
DANECEK P, INT J BIOIN IN PRESS
[9]  
DeLano W.L., 2002, The PyMOL molecular graphics system
[10]   A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse [J].
El Garch, H. ;
Minke, J. M. ;
Rehder, J. ;
Richard, S. ;
Toulemonde, C. Edlund ;
Dinic, S. ;
Andreoni, C. ;
Audonnet, J. C. ;
Nordgren, R. ;
Juillard, V. .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 123 (3-4) :230-239